And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to hang with our short people, escort Mrs. Pharmalot to a theatrical extravaganza, and take a nap or three. And what about you? Once again, we will remind you that this is a lovely time of year to fill your baskets with apples or, if you feel brave, search for the Great Pumpkin. You could also winterize your castle or make time for someone special. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The chief executives of the three largest U.S. drug distributors and a large drug maker have been summoned to appear before a federal judge to discuss a proposal to resolve thousands of lawsuits alleging they fueled the U.S. opioid crisis, Reuters reports. The order by U.S. District Judge Dan Polster in Cleveland came as the distributors — McKesson (MCK), Cardinal Health (CAH), and AmerisourceBergen (ABC) — and Teva Pharmaceutical (TEVA) moved to reach a deal ahead of a trial before him that begins on Monday. Attorneys general of North Carolina, Pennsylvania, Texas, and Tennessee also will participate, along with the lead lawyers for the counties, cities, Native American tribes and other groups that have filed suit against the drug makers, the Washington Post notes.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy